Keywords: rx, drug, sales, growth, slows, result, factors

US 2007 Rx drug sales growth slows to 3.8%

Article | 24 March 2008

Print This

As a result of factors such as generic competition for branded medicines, fewer new product approvals, the impact of safety ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in